November 2015 - ICLUSIG^® (ponatinib) Reimbursed for Chronic Myeloid Leukaemia (CML)

ST achieves PBS reimbursement for ICLUSIG^® (ponatinib) in Australia

November 2015 - ICLUSIG® (ponatinib) Reimbursed for Chronic Myeloid Leukaemia (CML)